Tekla Life Sciences Inves... (HQL)

AI Score

Unlock

11.80

0.14 (1.20%)

At close: Apr 17, 2025, 3:59 PM

11.75

-0.50%

After-hours: Apr 17, 2025, 08:00 PM EDT

Tekla Life Sciences Investors Ratios and Metrics

Financials in USD. Fiscal year is October - September.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Sep 30, 2024	Mar 31, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021	Mar 31, 2021	Sep 30, 2020	Mar 31, 2020	Sep 30, 2019	Mar 31, 2019	Sep 30, 2018	Mar 31, 2018	Sep 30, 2017	Mar 31, 2017	Sep 30, 2016	Mar 31, 2016
PE Ratio	3.10	1.83	-7.29	2.70	-3.1	-1.36	3.89	3.79	1.12	2.91	-2.84	-2.48	2.40	-5.14	2.77	3.83	1.69	-1.3
PEG Ratio	-0.09	-0.00	0.05	-0.01	0.05	0.00	1.26	-0.06	0.01	-0.01	0.13	0.01	-0.01	0.04	0.05	-0.07	-0.01	-0.04
PS Ratio	226.61	178.52	11.30	189.26	16.17	40.89	32.11	16.48	25.31	15.59	271.25	345.00	469.34	407.03	519.77	519.16	538.37	504.51
PB Ratio	0.94	0.84	0.83	0.86	0.88	0.96	0.98	0.95	0.86	0.88	0.93	0.91	0.98	0.93	0.00	0.00	0.00	0.00
P/FCF Ratio	n/a	n/a	n/a	n/a	n/a	n/a	-1.38B	-1.29B	n/a	n/a	-1.15B	-1.26B	n/a	n/a	n/a	n/a	n/a	n/a
P/OCF Ratio	n/a	n/a	n/a	n/a	n/a	n/a	-1.38B	-1.29B	n/a	n/a	-1.15B	-1.26B	n/a	n/a	n/a	n/a	n/a	n/a
OCF/S Ratio	n/a	n/a	n/a	n/a	n/a	n/a	-0.00	-0.00	n/a	n/a	-0.00	-0.00	n/a	n/a	n/a	n/a	n/a	n/a
Debt / Equity Ratio	n/a	n/a	n/a	0.00	0.00	0.00	0.00	n/a	0.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Quick Ratio	n/a	0.20	n/a	-1.19	-6.46	-6.33	0.01	-23.75	0.13	-22.22	-4.4	4.95	4.76	6.22	5.53	51.59	7.56	6.58
Current Ratio	n/a	0.20	n/a	0.00	0.12	0.96	0.01	0.13	0.13	7.62	1.80	4.95	4.76	0.13	5.53	51.59	7.56	6.58
Asset Turnover	0.00	0.00	0.07	0.00	0.05	0.02	0.03	0.06	0.03	0.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Coverage	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.98	n/a	n/a	n/a	n/a	-0.00	n/a	n/a	n/a
Return on Equity	0.08	0.11	-0.03	0.08	-0.07	-0.18	0.06	0.06	0.19	0.08	-0.08	-0.09	0.10	-0.05	n/a	n/a	n/a	n/a
Return on Assets	0.08	0.11	-0.03	0.08	-0.07	-0.17	0.06	0.06	0.19	0.08	-0.08	-0.09	0.10	-0.05	n/a	n/a	n/a	n/a
Return on Invested Capital	n/a	n/a	-0.03	n/a	-0.07	-0.17	0.06	0.06	0.19	0.08	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	1.00	1.00	0.91	1.00	0.88	0.71	0.81	0.90	0.84	0.89	1.00	1.00	1.00	1.00	-5.41K	1.00	1.00	1.00
Net Profit Margin	18.30	24.33	-0.39	17.52	-1.31	-7.5	2.06	1.09	5.63	1.34	-23.88	-34.71	48.96	-19.8	46.85	33.88	79.51	-96.84
Pretax Profit Margin	18.30	24.33	-0.39	17.52	-1.31	-7.5	2.06	1.09	5.63	1.34	-23.88	-34.71	48.96	-19.8	46.85	33.88	79.51	-96.84
Operating Profit Margin	-0.66	-0.32	-0.39	-0.49	-1.31	-7.5	2.06	1.09	5.63	1.34	-1	-1.39	-1.85	-1.79	-2.35	-2.25	-2.44	-2.84
FCF Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	48.67	-0.39	n/a	-1.31	-7.5	2.06	1.09	5.63	1.34	n/a	n/a	n/a	n/a	49.20	36.13	81.95	-93.99